FDA.reportPublic FDA data

tirzepatide 5 MG per dose (20 MG in 2.4 ML) Pen Injector

RxCUI
2734644
RxNorm name
tirzepatide 5 MG per dose (20 MG in 2.4 ML) Pen Injector
Display name
tirzepatide 5 MG per dose (20 MG in 2.4 ML) Pen Injector
Full name
tirzepatide 5 MG per dose (20 MG in 2.4 ML) Pen Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
487cd7e7-434c-4925-99fa-aa80b1cc776btirzepatide 20 MG per 2.4 ML Pen InjectorSY38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
487cd7e7-434c-4925-99fa-aa80b1cc776btirzepatide 5 MG per dose (20 MG in 2.4 ML) Pen InjectorPSN38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
487cd7e7-434c-4925-99fa-aa80b1cc776b2.4 ML tirzepatide 8.33 MG/ML Pen InjectorSCD38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc0tirzepatide 5 MG per dose (20 MG in 2.4 ML) Pen InjectorPSN38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc0tirzepatide 20 MG per 2.4 ML Pen InjectorSY38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc02.4 ML tirzepatide 8.33 MG/ML Pen InjectorSCD38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422